论文部分内容阅读
勃起功能障碍(ED)被公认为是一种极具代表性的心身疾病。社会心理因素在ED的发病过程中起到了关键性作用。ED对患者及其伴侣的社会心理健康以及人际关系也会产生重大影响。治疗上既包括性心理治疗,又需要适当的药物等治疗,“心身同治”是其治疗的核心。而随着健康医学模式的发展,ED的治疗目标也随之发生了巨大变革,不再单单追求阴茎勃起的硬度和维持时间,更为注重重建患者和伴侣之间自然和睦的性生活以及亲密无间的伴侣关系。新型5型磷酸二酯酶抑制剂他达拉非可有效提高各种病因和程度的ED患者勃起功能,同时明显降低患者的性时间顾虑,并很好地满足了患者及其伴侣的治疗预期,使患者及其伴侣回归正常、自然的性生活,给患者和伴侣带来巨大的社会心理收益。
Erectile dysfunction (ED) is recognized as a very representative psychosomatic disease. Psychosocial factors play a key role in the pathogenesis of ED. ED also has a significant impact on the psychosocial and interpersonal relationships of patients and their partners. Treatment includes both psychological treatment, but also the need for appropriate drugs and other treatment, “Heart and body” is the core of its treatment. With the development of the medical model of health, the therapeutic goals of ED have also undergone tremendous changes. They are no longer pursuing the hardness and maintenance of penile erection alone, they are paying more attention to reconstructing a natural and harmonious sex life between patients and their partners Partnership. Tadalafil, a novel type 5 phosphodiesterase inhibitor, is effective in enhancing erectile function in ED patients with various etiologies and degrees, while significantly reducing the patient’s sexual time concerns and meeting well the expectations of patients and their partners for treatment, So that patients and their partners return to normal, natural sex life, to patients and partners bring huge social and psychological benefits.